Alternative Treatment of NMSC Recurrent with NILS

Aferdita Stroka Koka, Laver Stroka, B. Çela, Ronny Khadra, A. Guy, F. Hyseni, J. Musa
{"title":"Alternative Treatment of NMSC Recurrent with NILS","authors":"Aferdita Stroka Koka, Laver Stroka, B. Çela, Ronny Khadra, A. Guy, F. Hyseni, J. Musa","doi":"10.26502/jcsct.5079126","DOIUrl":null,"url":null,"abstract":"Throughout 2018 in the \"STROKA\" clinic in Tirana, are presented for alternative treatment 28 patients with recurrent non melanoma skin cancer (NMSC) after standard treatment with surgery, radiotherapy or together for one or more lesions. All patients are diagnosed with Basal Cell Carcinoma and Squamous Cell Carcinoma, and are treated with NILS which contains extracts of some Albanian plants such as Allium sativum, Juglans regia and Laurus nobilis. According to a certain methodology, the treatment of patients lasts from one to three months until the complete destruction of the tumor and the regeneration of the area below and around it. From the first session, the measure of the tumor was reduce and all the surface that has absorbed the Nils, was turn in a cruste. The crustes falls one after another until the tumor mass has end and the sound layer was reached. At this point, we stoped the sessions of treatment, because the process of regeneration starts. NILS solution is J Cancer Sci Clin Ther 2021; 5 (3): 405-413 DOI: 10.26502/jcsct.5079126 Journal of Cancer Science and Clinical Therapeutics 406 applied topically and the number of sessions varied from 314 in our 28 patients. After complete recovery, all are advised for periodic check-ups after 1, 2, 3, 6, 12, 18, 24, 30 and 36 months, without limiting them further.","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer science and clinical therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/jcsct.5079126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Throughout 2018 in the "STROKA" clinic in Tirana, are presented for alternative treatment 28 patients with recurrent non melanoma skin cancer (NMSC) after standard treatment with surgery, radiotherapy or together for one or more lesions. All patients are diagnosed with Basal Cell Carcinoma and Squamous Cell Carcinoma, and are treated with NILS which contains extracts of some Albanian plants such as Allium sativum, Juglans regia and Laurus nobilis. According to a certain methodology, the treatment of patients lasts from one to three months until the complete destruction of the tumor and the regeneration of the area below and around it. From the first session, the measure of the tumor was reduce and all the surface that has absorbed the Nils, was turn in a cruste. The crustes falls one after another until the tumor mass has end and the sound layer was reached. At this point, we stoped the sessions of treatment, because the process of regeneration starts. NILS solution is J Cancer Sci Clin Ther 2021; 5 (3): 405-413 DOI: 10.26502/jcsct.5079126 Journal of Cancer Science and Clinical Therapeutics 406 applied topically and the number of sessions varied from 314 in our 28 patients. After complete recovery, all are advised for periodic check-ups after 1, 2, 3, 6, 12, 18, 24, 30 and 36 months, without limiting them further.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
NMSC复发与NILS的替代治疗
2018年,在地拉那的“STROKA”诊所,28名复发性非黑色素瘤皮肤癌(NMSC)患者在接受手术、放疗或联合治疗一个或多个病变的标准治疗后,接受替代治疗。所有患者都被诊断为基底细胞癌和鳞状细胞癌,并接受NILS治疗,NILS含有一些阿尔巴尼亚植物的提取物,如Allium sativum、Juglans regia和Laurus nobilis。根据一定的方法,患者的治疗持续一到三个月,直到肿瘤完全破坏,肿瘤下方和周围区域再生。从第一阶段开始,肿瘤的尺寸减小,所有吸收了Nils的表面都变成了硬壳。外壳一个接一个地落下,直到肿瘤结束,到达声层。在这一点上,我们停止了治疗,因为再生过程开始了。NILS解决方案是《癌症科学与临床杂志》2021;5 (3): 405-413 DOI: 10.26502/jcsct.5079126癌症科学与临床治疗杂志406例局部应用治疗次数从28例患者的314次不等。完全康复后,建议所有患者在1、2、3、6、12、18、24、30和36个月后进行定期检查,不作进一步限制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Web Application for Predicting Drug Combination Efficacy Using Monotherapy Data and IDACombo. Biophysical and Biological Mechanisms of Tumor Treating Fields in Glioblastoma. Small-Cell Lung Cancer in a Cancer Center in Colombia Epidemiology, Treatment, and Evolution of Glioblastoma in a Low-Income Country: Moroccan Experience Mycobacterium Bovis-Related Abdominal Aortic Aneurysm after Intravesical Bacillus Calmette-Guérin Therapy for Non-Muscle Invasive Bladder Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1